These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel disease as a risk factor for colorectal cancer. Lukas M Dig Dis; 2010; 28(4-5):619-624. PubMed ID: 21088413 [TBL] [Abstract][Full Text] [Related]
10. The histological diagnosis of dysplastic and neoplastic lesions in inflammatory bowel disease: a pathological perspective. Usaj S; Tarabar D; Cuk V; Cerovic S; Brajukovic G; Panisic M; Klem I; Eric Z Acta Chir Iugosl; 2004; 51(2):109-16. PubMed ID: 15771301 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Itzkowitz SH; Harpaz N Gastroenterology; 2004 May; 126(6):1634-48. PubMed ID: 15168373 [TBL] [Abstract][Full Text] [Related]
12. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience. Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085 [TBL] [Abstract][Full Text] [Related]
13. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk? Breynaert C; Vermeire S; Rutgeerts P; Van Assche G Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276 [TBL] [Abstract][Full Text] [Related]
14. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. Zhang R; Lauwers GY; Choi WT J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic problems and advances in inflammatory bowel disease. Odze R Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200 [TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study. Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599 [TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk. Herszényi L; Barabás L; Miheller P; Tulassay Z Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497 [TBL] [Abstract][Full Text] [Related]
18. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance. Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526 [TBL] [Abstract][Full Text] [Related]
19. Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms. Connelly TM; Berg AS; Harris LR; Brinton DL; Hegarty JP; Deiling SM; Stewart DB; Koltun WA Surgery; 2014 Aug; 156(2):253-62. PubMed ID: 24947639 [TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]